Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
NCT04452305 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2026-04-22
Summary
Spermatogonial stem cell transplantation through ultrasound guided rete testis injection and testicular tissue grafting will be performed for participants who have frozen testicular tissue prior to gonadotoxic therapy. The purpose of this study is to test the safety and feasibility of these transplant technologies and restore fertility for these participants.
Conditions
- Infertility, Male
- Cancer
- Autoimmune Disorder
Interventions
- PROCEDURE
-
Spermatogonial Stem Cell Transplant and Testicular Tissue Grafting
Spermatogonial stem cell transplant and testicular tissue grafting is performed to produce sperm.
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Kyle E Orwig, PhD · University of Pittsburgh
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-10
- Primary Completion
- 2029-12-28
- Completion
- 2030-05-31
Countries
- United States
Study Locations
More Related Trials
-
A Study to Test a Measure of Symptoms of Older Men With Low Testosterone On and Off Testosterone Replacement Treatment (P05815)
NCT00254553 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)
NCT03687606 ·Status: UNKNOWN ·Phase: PHASE4
-
Testosterone Undecanoate and Quality of Life of Men and Spouses
NCT01758029 ·Status: UNKNOWN
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel
NCT01665599 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
NCT02149264 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate
NCT00555087 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Testosteron Replacement Treatment on the Fibroblast Growth Factor-23, Asymmetric Dimethylarginine and Vitamin D Levels in the Congenital Hypogonadotropic Hypogonadism
NCT02111473 ·Status: COMPLETED ·Phase: PHASE4
-
Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
NCT04301765 ·Status: RECRUITING ·Phase: PHASE2
-
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
NCT02159469 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients
NCT02248467 ·Status: COMPLETED
-
Effect of Testosterone Replacement on Insulin Resistance
NCT00487734 ·Status: COMPLETED ·Phase: PHASE4
-
Safety of Testosterone Undecanoate i.m. in Hypogonadal Men
NCT00452322 ·Status: COMPLETED ·Phase: PHASE2
-
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NCT02777242 ·Status: COMPLETED ·Phase: PHASE2
-
Testosterone Replacement in Men With Diabetes and Obesity
NCT01127659 ·Status: COMPLETED ·Phase: PHASE4
-
Leuprolide in Treating Adults With Hypogonadotropism
NCT00004438 ·Status: COMPLETED ·Phase: NA
-
7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy
NCT06191575 ·Status: SUSPENDED
-
Effect of Dose Fractionation of Testosterone Cypionate on Transgender Men with Erythrocytosis
NCT05487794 ·Status: COMPLETED ·Phase: NA
-
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
NCT06689085 ·Status: RECRUITING ·Phase: PHASE3
-
Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency
NCT03716739 ·Status: COMPLETED ·Phase: PHASE2
-
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
NCT03063125 ·Status: COMPLETED
-
Testosterone Treatment in Men With Chronic Kidney Disease
NCT05249634 ·Status: RECRUITING ·Phase: PHASE2
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Androgen Regulation of Priapism in Sickle Cell Disease
NCT01940718 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients
NCT00965341 ·Status: COMPLETED ·Phase: PHASE3